Today’s societal development is not sustainable. The transportation sector has the potential role to be a tremendous lever for sustainability due to its central position in the societal structure as well as for the current unsustainable trends that occur in this system. Recommendations to public transportation providers were made by highlighting the main existing gaps between the current transportation system and an envisioned future transportation system that could exist in a sustainable society. To highlight these gaps, multiple perspectives were considered. These perspectives were enabled by e.g. User Journey Maps at the individual level and a holistic perspective over the broader urban transport system. The premise is that in order to increase use rates of public transportation, there is a need to better assess and address urban travellers' needs when commuting. For providers to have a strategic, stepwise approach and to be able to bring the public transportation system towards sustainability, the authors recommended that public transportation providers prioritize and implement future actions aligned with the three prioritization questions presented at the strategic level of the Framework for Strategic Sustainable Development and by defining a criterion that would emphasize that the users’ needs of importance highlighted in the study are fulfilled.

Karolinska University Hospital's problem regarding the CAR-T cells' journey has been impacting thetreatment of patients and therefore a solution was in dire need to be presented. Visual mappingmethods have been used to review and map the journey with the aim of identifying factors that seemto be impacted. Previous research concerns user journey mapping, mapping methods andcollaboration theories. To carry out the mapping of the cells' journey, semi-structured interviews werecarried out with selected experts within the research area. These experts consisted of the unit managerat the apheresis clinic at Karolinska, a medically responsible researcher at the apheresis clinic atKarolinska and a senior patient operation manager at Bristol Myers Squibb. Their expertise andexperiences were the basis for the visual mapping, and this provided deep insights into the researcharea where the problem has been identified. Lastly, the data was mapped to create a visual map oftheir current management approach regarding CAR-T cell therapy where their experiences around theproblems could be identified. As a result, a solution to the identified factors that expose the cells tothe risks is presented with several visual maps and a proposed solution for a redesign withinKarolinska.